Mesoblast (MESO) Net Income (2014 - 2023)

Mesoblast (MESO) has reported Net Income for 10 consecutive years, with -$21.6 million the latest figure, recorded in Q2 2023.

• Quarterly Net Income fell 2.34% year-over-year to -$21.6 million in Q2 2023, while the trailing twelve-month figure through Dec 2024 was -$21.6 million (down 200.3% YoY) and the FY2025 annual result came in at -$102.1 million, down 16.13% from the prior year.
• Net Income eased to -$21.6 million in Q2 2023 per MESO's latest filing, from $18.6 million in the prior quarter.
• Over the last five years, Net Income for MESO reached as high as $25.9 million in Q4 2021 and fell as low as -$29.4 million in Q2 2020.
• A 5-year average of -$11.3 million and a median of -$20.8 million in 2021 frame the typical range for Net Income.
• Annual changes were most pronounced in 2020 — Net Income tumbled 347.56% — and 2021, when it soared 193.04%.
• Year by year, Net Income stood at -$22.3 million in 2019, then decreased by 24.97% to -$27.9 million in 2020, then surged by 193.04% to $25.9 million in 2021, then declined by 5.62% to $24.5 million in 2022, then slumped by 188.11% to -$21.6 million in 2023.
• According to Business Quant data, Net Income over the past three periods registered -$21.6 million, $18.6 million, and $24.5 million for Q2 2023, Q1 2023, and Q4 2022 respectively.